Recent coverage by The New York Times and The Washington Post has raised questions about the Food and Drug Administration (FDA) under Commissioner Marty Makary. The reports suggest that FDA scientists are allegedly involved in a cover-up, though specific details remain unverified as of May 7, 2026.
Marty Makary, a surgeon and author known for his critiques of medical overregulation, was appointed FDA commissioner in 2025. His leadership has been marked by efforts to reform drug approval processes and increase transparency, which have drawn both support and criticism.
The NYT and WaPo articles, published in early May 2026, accuse the agency of suppressing internal data. However, the FDA has not issued an official response to these allegations, and independent verification of the claims is pending.
This controversy highlights ongoing tensions between the FDA and media outlets over public health communication. The situation remains fluid, and further developments are expected.
